Grant✓ Small businesses may apply
Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed)
National Institutes of Health
Program funding
$3,000,000
- Opportunity #
- RFA-DA-27-015
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.279
- Status
- posted
- Posted
- May 21, 2026
- Closes
- Sep 30, 2026
- Funding instrument
- Cooperative Agreement
- Category
- Health
- Cost sharing required
- No
Who can apply
- •State governments
- •County governments
- •For profit organizations other than small businesses
- •Independent school districts
- •Small businesses
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •Special district governments
- •Public and State controlled institutions of higher education
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •Public housing authorities/Indian housing authorities
- •Native American tribal governments (Federally recognized)
- •City or township governments
- •Native American tribal organizations (other than Federally recognized tribal governments)
- •Private institutions of higher education
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Synopsis
The purpose of this notice of funding opportunity (NOFO) is to establish a Center that trains researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics and to advance the best concepts through initial experiments via technical and financial support.
Contact
National Institutes of Health · nidagmbemail@nida.nih.gov